# ABLAVAR
> **NDA021711** · New Drug Application · Sponsor: LANTHEUS MEDCL · Approved 2008-12-22
## Drug
- **FDA Application Number:** NDA021711
- **Application type:** New Drug Application
- **Brand name:** ABLAVAR
- **Generic name:** Gadofosveset Trisodium
- **Active ingredients:** GADOFOSVESET TRISODIUM
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Discontinued
- **Sponsor:** LANTHEUS MEDCL
- **First approval:** 2008-12-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021711)
---
*AI Analytics · CC0 1.0*